Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway
Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway
Abstract Background Silencing of the periostin gene (POSTN) can inhibit the biological process of several different cancers, and this inhibition may be related to down-regulation of PI3K/AKT signaling. However, the effect of POSTN on the progression, proliferation, and invasion of osteosarcoma (OS) remain unclear. Methods We used the Gene Expression Omnibus (GEO) database to screen datasets on in situ OS and lung metastases to identify core genes and potential pathways. We used additional bioinformatics tools to identify protein–protein interactions (PPIs) and gene networks, and selected the top seven genes whose expression had the strongest correlations with other genes. Results The results indicated that POSTN was a major hub gene. Subsequent analysis of gene expression profiles showed that POSTN was highly expressed in 262 cases with sarcoma and expression was closely related to poor prognosis. We also performed enrichment analysis to identify differentially expressed genes and used real-time PCR, western blotting, and immunohistochemistry analyses to measure POSTN expression in cells and tissues. Transfection of a POSTN-shRNA plasmid into cultured OS cells (Saos-2) effectively inhibited the proliferation, invasion, and migration of these cells. Taken together, our results suggest that POSTN may play a role in promoting the proliferation and metastasis of OS by activation of the PI3K/Akt signaling pathway. Conclusions Our results provide a preliminary characterization of the mechanism by which POSTN may regulate the migration and invasion of OS cells and also provide a theoretical basis for identifying biomarkers that have potential use for the diagnosis and treatment of OS.
- Shanxi Medical University China (People's Republic of)
- Beijing Shijitan Hospital China (People's Republic of)
- Xiamen University China (People's Republic of)
- Capital Medical University China (People's Republic of)
- Second Hospital of Shanxi Medical University China (People's Republic of)
Osteosarcoma, QH573-671, Proliferation, POSTN (Periostin), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastasis, Cytology, Primary Research, RC254-282, Pathway
Osteosarcoma, QH573-671, Proliferation, POSTN (Periostin), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastasis, Cytology, Primary Research, RC254-282, Pathway
8 Research products, page 1 of 1
- 2011IsAmongTopNSimilarDocuments
- 2016IsAmongTopNSimilarDocuments
- 2021IsAmongTopNSimilarDocuments
- 2020IsAmongTopNSimilarDocuments
- 2021IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).13 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
